-
Monlunabant (INV-202, MRI-1891, or S-MRI-1891) is a
peripherally selective cannabinoid receptor 1
inverse agonist,
discovered as a β-arrestin-2-biased...
- (dronabinol) UR-144 WIN 55,212-2
Yangonin Inverse agonists AM-251 INV-202
Monlunabant Rimonabant Surinabant Taranabant TM-38837
Zevaquenabant Antagonists AM-6545...
- (dronabinol) UR-144 WIN 55,212-2
Yangonin Inverse agonists AM-251 INV-202
Monlunabant Rimonabant Surinabant Taranabant TM-38837
Zevaquenabant Antagonists AM-6545...
-
Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470
Monlunabant MRL-650 NESS-0327 NIDA-41020 O-606 O-1184 O-1248 O-1918 O-2050 O-2654...
-
Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470
Monlunabant MRL-650 NESS-0327 NIDA-41020 O-606 O-1184 O-1248 O-1918 O-2050 O-2654...
-
Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470
Monlunabant MRL-650 NESS-0327 NIDA-41020 O-606 O-1184 O-1248 O-1918 O-2050 O-2654...
- (dronabinol) UR-144 WIN 55,212-2
Yangonin Inverse agonists AM-251 INV-202
Monlunabant Rimonabant Surinabant Taranabant TM-38837
Zevaquenabant Antagonists AM-6545...
-
Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470
Monlunabant MRL-650 NESS-0327 NIDA-41020 O-606 O-1184 O-1248 O-1918 O-2050 O-2654...
- CB1
antagonist and CB2 agonist)
Rimonabant Taranabant Zevaquenabant Monlunabant INV-202
Lipoxin A4 – endogenous, PAM ZCZ-011 – PAM
Pregnenolone – endogenous...
-
Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470
Monlunabant MRL-650 NESS-0327 NIDA-41020 O-606 O-1184 O-1248 O-1918 O-2050 O-2654...
